Net Cash Provided by (Used in) Financing Activities in USD of SELLAS Life Sciences Group, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • SELLAS Life Sciences Group, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $23.6M, a 11.5% decline year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $46.8M, a 110% increase from 2023.
  • SELLAS Life Sciences Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22.3M, a 7.33% decline from 2022.
  • SELLAS Life Sciences Group, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $24.1M, a 99.4% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

SELLAS Life Sciences Group, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $23.6M -$3.07M -11.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $26.6M +$7.74M +41% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $18.9M +$18.9M +40121% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $47K -$2.95M -98.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $3M -$3.3M -52.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $6.3M +$4.07M +183% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $2.23M -$2.51M -52.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $4.74M +$4.74M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $0 -$19.3M -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $19.3M -$22M -53.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $41.3M +$26.6M +180% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $14.7M +$14.6M +15900% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $92K -$2.06M -95.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q1 2012 $2.15M -$5.14M -70.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $7.29M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14

SELLAS Life Sciences Group, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $46.8M +$24.4M +110% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $22.3M -$1.76M -7.33% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $24.1M +$12M +99.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $12.1M -$26.4M -68.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $38.4M +$18.9M +96.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $19.6M -$3.55M -15.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 $23.1M +$17.6M +318% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $5.53M -$11M -66.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $16.5M -$27.3M -62.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-13
2015 $43.8M +$19.6M +80.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 $24.3M -$31.7M -56.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $55.9M +$13.5M +31.8% Jan 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
2012 $42.4M +$23.2M +121% Jan 1, 2012 Dec 31, 2012 8-K 2015-12-04
2011 $19.2M +$7.63M +65.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $11.6M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.